Aigen Investment Management, LP Neogenomics Inc Transaction History

Aigen Investment Management, LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$13.01 - $15.77 $33,006 - $40,008	-2,537 Reduced 10.6%	21,392 $296,000
Q1 2024 May 14, 2024	BUY	$14.06 - $16.79 $336,441 - $401,767	23,929 New	23,929 $376,000
Q3 2023 Nov 13, 2023	BUY	$12.15 - $17.85 $160,768 - $236,191	13,232 New	13,232 $162,000
Q1 2022 May 05, 2022	SELL	$12.15 - $35.28 $103,675 - $301,044	-8,533 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$30.49 - $48.49 $260,171 - $413,765	8,533 New	8,533 $274,000
Q2 2020 Aug 10, 2020	SELL	$24.21 - $31.02 $74,324 - $95,231	-3,070 Closed	0 $0
Q1 2020 May 08, 2020	SELL	$20.5 - $34.53 $284,827 - $479,759	-13,894 Reduced 81.9%	3,070 $85,000
Q4 2019 Feb 04, 2020	BUY	$18.96 - $29.84 $321,637 - $506,205	16,964 New	16,964 $496,000

294

124M

698K

120K

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.86B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

Get notified when there are updates to the investment portfolio of Aigen Investment Management, LP, based on Form 13F filings with the SEC.

Stay updated on Aigen Investment Management, LP with notifications on news.